- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.09.24 | Vapotherm, Inc.: Vapotherm Announces Closing of Merger | 615 | PR Newswire | EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and... ► Artikel lesen | |
| 12.08.24 | Vapotherm, Inc.: Vapotherm Reports Second Quarter 2024 Financial Results | 189 | PR Newswire | EXETER, N.H., Aug. 12, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced second quarter 2024 financial results and related highlights.
Second Quarter... ► Artikel lesen | |
| VAPOTHERM Aktie jetzt für 0€ handeln | |||||
| 17.06.24 | Vapotherm, Inc.: Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private | 240 | PR Newswire | EXETER, N.H., June 17, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has signed a definitive merger agreement with a newly-formed entity... ► Artikel lesen |
3 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| MEDTRONIC | 76,78 | -0,29 % | Medtronic: Fast Company: Healthcare Innovation Could Be at Risk | It's not for the reason you think. NORTHAMPTON, MA / ACCESS Newswire / May 14, 2025 / Imagine someone with Parkinson's sipping their morning coffee with a steady hand. A person with chronic pain or... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,50 | +0,36 % | Intuitive Surgical Promotes President Dave Rosa As CEO | SUNNYVALE (dpa-AFX) - Intuitive Surgical, Inc. (ISRG), a biotechnology company, on Thursday announced the promotion of President Dave Rosa as Chief Executive Officer, effective from July 1.... ► Artikel lesen | |
| THERMO FISHER | 361,85 | -0,04 % | Cybin Inc (2): Cybin hires Thermo Fisher for phase 3 supply of CYB003 | ||
| ROKU | 62,80 | +0,22 % | Roku Analyst Says TV's Future Hinges On This 'Powerful' Cost Saver, But It's Still Early | ||
| BECTON DICKINSON | 153,50 | -0,36 % | BD files patent infringement lawsuit against Baxter over infusion pump tech | ||
| DEXCOM | 76,66 | +0,05 % | DexCom Promotes COO Jacob Leach To Additional Role Of President | WASHINGTON (dpa-AFX) - DexCom, Inc. (DXCM) announced Tuesday the promotion of Jacob Leach to president, in addition to his current role as chief operating officer, which he has held since 2022.With... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 93,80 | 0,00 % | Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? | ||
| RESMED | 222,50 | +0,09 % | Resmed, Inc.: Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 | SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the... ► Artikel lesen | |
| BAXTER | 27,655 | -0,38 % | Baxter-Aktie mit Kursgewinnen (28,4412 €) | Im Plus liegt gegenwärtig der Anteilsschein von Baxter . Die Aktie notiert derzeit bei 31,95 US-Dollar. Im US-amerikanischen Wertpapierhandel hat sich heute das Wertpapier von Baxter zwischenzeitlich... ► Artikel lesen | |
| DAVITA | 124,95 | -2,69 % | DaVita Inc. Reveals Retreat In Q1 Profit | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) reported a profit for first quarter that decreased from the same period last yearThe company's bottom line totaled $162.92 million, or $2.00 per share.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| ZIMMER BIOMET | 85,56 | -1,04 % | Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish? | ||
| SONOMA PHARMACEUTICALS | 3,030 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain | BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| TANDEM DIABETES | 20,320 | +0,10 % | Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set |
VAPOTHERM INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VAPOTHERM INC finden Sie auf Wallstreet Online.